Sign in

NCT07239167Enrolling by invitation

A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change

Source: ClinicalTrials.gov · Last updated 15 Sept 2026

Brief summary (registry, in English)

This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment. Participants underwent a battery of measurements and questionnaires, including height, weight, waist circumference, blood pressure, blood tests, and questionnaires addressing diet, exercise, stress, sleep, measure handgrip strength ,and psychological well-being.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
500 (estimated)
First submitted
16 Nov 2025
Start date
5 Jun 2025
Primary completion date
8 Apr 2027
Lead sponsor
National Taiwan University Hospital
NCT number
NCT07239167

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 5 Jun 2025 to the primary completion date, 8 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individuals taking medications that significantly affect their weight (e.g., long-term steroids or antipsychotics) and cannot be discontinued.

Other illness

  • Individuals with significant mental illness (e.g., schizophrenia, severe depression) or cognitive impairment that may affect their ability to consent or cooperate with the study.
  • Individuals with severe organ dysfunction (e.g., end-stage renal disease, cirrhosis, congestive heart failure, etc.).

Other

  • Pregnant or breastfeeding women.
  • Individuals deemed unsuitable for participation in this study by the study leader (e.g., individuals who are expected to be unable to complete follow-up).

Who the study is looking for

  • Adults aged 18 years or older, regardless of gender.
  • Body mass index (BMI) ≥ 27 kg/m², or ≥ 24 kg/m² with one or more obesity-related comorbidities.
  • Willing to undergo any form of weight loss intervention.
  • Able to read and understand Chinese, willing to complete questionnaires, blood tests, and follow-up follow-up.
  • Voluntarily consent to participate and be willing to complete the subject consent form.

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
No.7, Chung Shan S. Rd.(Zhongshan S. Rd.)
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.